Sumitomo Mitsui Financial Group’s Gilead Sciences GILD Stock Holding History

Sumitomo Mitsui Financial Group’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-280	Closed	-$21K	–	202
2021 Q4	$21K	Sell	280 -240	-46%	-$16.5K	﹤0.01%	183
2021 Q3	$37K	Buy	+520	New	+$36.5K	﹤0.01%	172
2020 Q4	–	Sell	-234	Closed	-$15K	–	161
2020 Q3	$15K	Buy	+234	New	+$16.2K	﹤0.01%	150
2019 Q4	–	Sell	-2,667	Closed	-$168K	–	135
2019 Q3	$168K	Buy	+2,667	New	+$174K	0.01%	101
2019 Q2	–	Sell	-1,225	Closed	-$78K	–	122
2019 Q1	$78K	Buy	+1,225	New	+$81.4K	0.01%	98
2018 Q4	–	Sell	-1,300	Closed	-$100K	–	116
2018 Q3	$100K	Buy	+1,300	New	+$98.2K	0.01%	91
2018 Q1	–	Sell	-630	Closed	-$46K	–	130
2017 Q4	$46K	Buy	+630	New	+$47.8K	0.01%	84
2017 Q3	–	Sell	-559	Closed	-$40K	–	111
2017 Q2	$40K	Buy	+559	New	+$37.2K	0.01%	89

Other funds holding GILD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Sumitomo Mitsui Financial Group's GILD Position: Q1 2022 in Review

Sumitomo Mitsui Financial Group sold out of Gilead Sciences (GILD) in Q1 2022, closing a stake of 280 shares — an estimated $21K sold.

Sumitomo Mitsui Financial Group first reported a position in GILD in Q2 2017 and held it in 8 quarters. The position peaked at $168K in Q3 2019. 1,600 funds tracked by Wall St. Rank hold GILD as of Q1 2022.

Sumitomo Mitsui Financial Group reported no remaining Gilead Sciences position as of Q1 2022 after selling out during the quarter.
Sumitomo Mitsui Financial Group sold 280 Gilead Sciences shares in Q1 2022, an estimated $21K.
Sumitomo Mitsui Financial Group first reported a position in Gilead Sciences in Q2 2017 and held it in 8 quarters.
Sumitomo Mitsui Financial Group's Gilead Sciences position peaked at $168K in Q3 2019.
1,600 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2022.

Based on Sumitomo Mitsui Financial Group's 13F filing for Q1 2022, filed 12 May 2022.